Omega Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of genomic diseases.
Business Model:
Revenue: $1.5M
Employees: 51-200
Omega was acquired by
Senda Biosciences.
The acquisition happend on 2020-08-01.
Details of the transaction were not public
Address: 20 Acorn Park Drive
City: Cambridge
State: MA
Zip: 02140
Country: US
Omega Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of genomic diseases.
Contact Phone:
+16179494360
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/30/2021
IPO Valuation:
$794M
Ticker Symbol:
OMGA
IPO Price:
$17/share
Amount Raised:
$126M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | IPO | $125.8M |
|
6/2018 | Series A | - | 8/2017 | Series A | 1 | $28.4M |
Flagship Pioneering Flagship Pioneering |
7/2020 | Series B | 2 | $85M |
Flagship Pioneering Flagship Pioneering HarbourVest Partners Flagship Pioneering Flagship Pioneering |
3/2021 | Series C | 9 | $126M |
BlackRock Cowen and Company Fidelity Management and Research Company Flagship Pioneering Invus LifeSci Venture Partners Logos Capital Mirae Asset Capital Point72 BlackRock Cowen and Company Fidelity Management and Research Company Flagship Pioneering Invus LifeSci Venture Partners Logos Capital Mirae Asset Capital Point72 |
6/2018 | Series A | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|